Statin meds safe for long-term use, study finds

Long-term use of statin drugs offer continuing benefits without serious safety issues, such as increased cancer risk, that some data had suggested could be a problem, a new 11-year study found. Report

Suggested Articles

The FDA has granted Amarin's Vascepa a possible blockbuster label expansion for CV risk reduction in patients with or without CV disease.

In a high-stakes patent lawsuit between CAR-T companies Bristol-Myers Squibb and Gilead Sciences, BMS has come up with a victory. 

It’s been a year of ups and downs for Pfizer’s Xeljanz. But the company is hoping to close on a high note, with help from a new extended-release pill.